Distinguished Awards

Distinguished Awards

Each year, the IASLC's honors professionals who have made major contributions to the field of thoracic cancers with its Distinguished Awards. 

Paul A. Bunn, Jr. Scientific Award

The Paul A. Bunn, Jr. Scientific Award recognizes an IASLC scientist for a lifetime achievement of scientific contributions to thoracic cancer research. Dr. Paul Bunn’s studies set worldwide standards for the treatment of lung cancer and identified issues of natural history and biomarkers of prognosis and therapy selection. Robert Ginsberg, MD, a thoracic surgeon from Toronto, Canada, earned the first award in 1994 for his contributions to the surgical treatment of early stage lung cancer. Initially named the Scientific Award, the IASLC renamed the award in honor of Dr. Bunn after he served as its executive director and CEO for 10 years.

Charles Rudin

2019 WINNER: CHARLES RUDIN, MD, PhD 


Dr. Rudin is the Sylvia Hassenfeld Professor and Chief of Thoracic Oncology at MSKCC, where he also co-directs the Druckenmiller Center for Lung Cancer Research. Dr. Rudin oversees a broad and integrated program of preclinical and clinical research in lung cancer, spanning from basic discovery science, preclinical modeling and novel therapeutic target identification, first-in-human phase I clinical testing, through leadership of definitive national and international phase III studies.

Dr. Rudin has a particular interest in small cell lung cancer (SCLC), and chairs the NCI SCLC Research Consortium, a national network of investigators studying SCLC oncogenesis, mouse and human preclinical modeling, genomic and epigenetic drivers, and therapeutic vulnerabilities. He also serves as the MSK PI for two Stand Up to Cancer (SU2C) grants, one focused on epigenetics and the other on KRAS targeting in lung cancer.

Mary J. Matthews Pathology/Translational Research Award

The Mary J. Matthews Pathology/Translational Research Award recognizes an IASLC scientist for a lifetime achievement in pathology and translational research of thoracic malignancies. Dr. Matthews served as a senior investigator and pathologist at the National Cancer Institute’s Medical Oncology Branch. She was pioneer in the foundation of the histologic subtypes of lung cancer and the relationship /between those subtypes and the clinical course of lung cancer. Geno Saccommano, MD, PhD, a physician and cancer researcher who dedicated his life to developing a pioneering technique to assist in the early detection of lung cancer was the first to receive the award in 1994.

WCLC19

2019 WINNER: ANDREW NICHOLSON, MD, PhD  

Prof. Nicholson trained in medicine at Oxford University and St Bartholomew’s Medical School and then specialized in pathology, specifically thoracic pathology, trained under Professor Bryan Corrin at the Royal Brompton Hospital, London. He has since worked there as a consultant since 1995, and as Honorary Professor in Respiratory Pathology, at the National Heart and Lung Institute, Imperial College, London since 2002. As well as being the lead for local thoracic pathology, he is referred over 300 cases each year, mainly cancer related, from clinicians and other pathologists both nationally and internationally. His research interests are thoracic cancers - common and rare lung cancers, mesotheliomas, thymic tumours - as well other thoracic diseases such as interstitial lung disease, and he has published over 400 peerreviewed papers. In relation to thoracic cancers, he is particularly interested in translational research. He is a Past Chair of the International Association for the Study of Lung Cancer (IASLC) Pathology Panel, and has been a longstanding member of the IASLC Staging and Prognostic Factors Committee. He has also sat on the IASLC Membership Committee. He was Specialist Advisory Panel for the Royal College of Pathologists, UK, for the past decade and is President Elect of the British Division of the International Academy of Pathologists. He has also co-authored Pathology of the Lung, second and third editions (Churchill Livingstone 2006 and 2011) with Bryan Corrin, was a Volume Editor of the 2015 WHO classification of lung, pleura, thymus and heart tumours and is an author of the AFIP Atlas of Tumor Pathology: Tumors of the Lower Respiratory Tract (2019).

Joseph W. Cullen Prevention/Early Detection Award

The Joseph W. Cullen Prevention/Early Detection Award recognizes an IASLC scientist for a lifetime achievement in the prevention of thoracic malignancies. Dr. Cullen served as the Deputy Director of the National Cancer Institute’s (NCI) Division of Cancer Prevention and Control. He created the Smoking, Tobacco and Cancer Program at the NCI in 1982. The winner of the first award in 1994 was Jesse Steinfeld, MD, the U.S. Surgeon General when the National Cancer Act of 1971 was enacted into federal law.

DA

2019 WINNER: DENISE R. ABERLE, MD  

Denise R. Aberle, MD is Professor of Radiology and Bioengineering at UCLA. She has been Vice Chair for Research in Radiological Sciences in the David Geffen School of Medicine at UCLA for 19 years. She previously served as President of the Society of Thoracic Radiology, Chair of the Lung Committee of the American College of Radiology Imaging Network (ACRIN), Deputy Chair of ACRIN, and co-chair of the Early Diagnosis and Detection Committee of ECOGACRIN. She is a fellow of the American Institute for Medical and Biomedical Engineering (AIMBE) and has received awards from the IASLC, the UCLA Clinical Translational Science Institute, the American Lung Association, ACRIN, the Society of Thoracic Radiology, and others for her work in lung cancer early detection. From 2000 to 2012, Dr. Aberle led the National Lung Screening Trial-ACRIN as principal investigator. Dr. Aberle obtained her MD degree from the University of Kansas Medical Center and completed a residency in internal medicine at Boston University Hospital (1980-1982), thereafter completing a residency in diagnostic radiology at UCLA. She completed fellowship training in thoracic imaging at the University of California San Francisco in 1987 before returning to UCLA to head the Thoracic Imaging Section. Her current research focuses on characterizing indeterminate lung nodules and early lung cancers using semantic, quantitative, and machine learning techniques in combination with clinical and molecular features.